Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
South Korean Biotech Platforms Drive Surge in Multibillion-Dollar Global Licensing Deals
Monday, November 17, 2025South Korean biotech firms accelerate global expansion with recordsetting licensing deals highlighting the regions rising competitiveness in drug development and platform innovation
China’s Groundbreaking Dual-Track Drug Reimbursement Reform Ushers in New Era for Pharma Market Access
Friday, November 14, 2025China introduces a dualtrack reimbursement system for innovative drugs offering new access channels for global pharma manufacturers
Numab Therapeutics Enters into Agreement with Kaken Pharmaceutical for Multispecific Antibody NM81 in Inflammatory Bowel Disease
Friday, November 14, 2025Numab Therapeutics and Kaken Pharmaceutical have entered into a new licence and codevelopment agreement to advance NM a multispecific antibody being developed for inflammatory bowel disease IBD
Kura Oncology and Kyowa Kirin Receive Approval for KOMZIFTI™ (ziftomenib for Relapsed or Refractory NPM1-Mutated AML
Friday, November 14, 2025Kura Oncology and Kyowa Kirin have received full approval from the US Food and Drug Administration FDA for KOMZIFTI ziftomenib a oncedaily oral therapy for adults with relapsed or refractory acute myeloid leukaemia AML
Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
Thursday, November 13, 2025Ascletis Pharma announces a major advance in GLPRGIPR and amylin receptor agonist coformulation targeting nextstage clinical development using its proprietary peptide technologies
Parabilis Medicines Receives FDA Fast Track Designation for FOG-001 in Desmoid Tumours
Thursday, November 13, 2025Parabilis Medicines has received Fast Track designation from the United States Food and Drug Administration FDA for FOG a firstinclass investigational therapy designed to treat desmoid tumours
Chiesi Group Enters into Agreement with Aliada Therapeutics to Advance Blood-Brain Barrier-Crossing Technology for Lysosomal Storage Disorders
Thursday, November 13, 2025Chiesi Group has entered into an exclusive licence agreement with Aliada Therapeutics to progress bloodbrain barrier BBBcrossing platform technology aimed at treating lysosomal storage disorders LSDs
March Biosciences Receives FDA RMAT Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma
Wednesday, November 12, 2025March Biosciences has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for its lead candidate MB
Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
Tuesday, November 11, 2025Shilpa Pharma Lifesciences receives the prestigious EcoVadis Gold Medal recognizing its excellence in sustainability within global pharmaceutical manufacturing
Novartis Expands Radioligand Therapy Manufacturing with New Facility in California
Tuesday, November 11, 2025Novartis has opened a new squarefoot radioligand therapy RLT manufacturing facility in Carlsbad California marking a major step in its US expansion strategy
